Insider: Anders Jack Chief Financial Officer - Revolution Medicines, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 125,512 | 0 | 125,512 |
| Value | $12,440,749.44 | $0.00 | $12,440,749.44 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/17/2026 | DDS | 2,753 | Direct | COM | $99.48 | $273,869.54 | 125,512 |
| 01/07/2026 | DDS | 10,000 | Direct | COM | $98.00 | $980,000.00 | 108,065 |
| 12/16/2025 | DDS | 3,104 | Direct | COM | $77.09 | $239,288.60 | 108,065 |
| 11/25/2025 | DDS | 5,418 | Direct | COM | $74.00 | $400,932.00 | 110,994 |
| 11/11/2025 | DDS | 10,000 | Direct | COM | $64.00 | $640,000.00 | 110,994 |
| 09/16/2025 | DDS | 2,320 | Direct | COM | $45.82 | $106,313.77 | 110,994 |
| 09/03/2025 | DDS | 5,238 | Direct | COM | $40.17 | $210,432.46 | 113,314 |
| 09/02/2025 | DDS | 4,762 | Direct | COM | $40.02 | $190,560.00 | 113,314 |
| 06/16/2025 | DDS | 2,170 | Direct | COM | $39.83 | $86,431.10 | 113,314 |
| 03/17/2025 | DDS | 1,864 | Direct | COM | $39.04 | $72,771.12 | 115,006 |
| 12/16/2024 | DDS | 2,635 | Direct | COM | $45.40 | $119,639.01 | 96,470 |
| 10/11/2024 | DDS | 10,000 | Direct | COM | $50.30 | $502,979.00 | 98,932 |
| 09/16/2024 | DDS | 2,244 | Direct | COM | $44.19 | $99,151.81 | 98,932 |
| 06/17/2024 | DDS | 1,893 | Direct | COM | $37.39 | $70,774.73 | 101,176 |
| 05/03/2024 | DDS | 10,000 | Direct | COM | $40.03 | $400,260.00 | 101,959 |
| 03/18/2024 | DDS | 1,261 | Direct | COM | $31.58 | $39,826.42 | 101,959 |
| 12/18/2023 | DDS | 1,775 | Direct | COM | $25.90 | $45,975.70 | 76,416 |
| 09/18/2023 | DDS | 1,427 | Direct | COM | $31.31 | $44,680.23 | 53,667 |
| 09/01/2023 | DDS | 20,000 | Direct | COM | $35.05 | $701,092.00 | 55,094 |
| 06/20/2023 | DDS | 1,249 | Direct | COM | $24.89 | $31,088.86 | 55,094 |
| 03/17/2023 | DDS | 665 | Direct | COM | $21.78 | $14,483.70 | 55,233 |
| 12/19/2022 | DDS | 658 | Direct | COM | $22.94 | $15,094.85 | 29,298 |
| 09/19/2022 | DDS | 449 | Direct | COM | $19.04 | $8,550.13 | 29,956 |
| 03/17/2022 | DDS | 159 | Direct | COM | $18.62 | $2,959.98 | 19,875 |
| 12/17/2021 | DDS | 170 | Direct | COM | $24.41 | $4,149.70 | 8,434 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research